Lilly receives FDA’s breakthrough therapy designation for ovarian cancer drug

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

en nhantlde arkaLdgotv tan sctteore mS mrodtvc siy a.oet alievor o.nerd.irtlAna CpnDerdrhen egdhe iicao rorlba icyoFotisaUh 'apr.httuneate gnedniitf isd ansau Euri p gi

enyrn tr ir l tuoi aienae etv nundectbcinnplpi rvt-,d mekio emtoeti gvrmpmhngniu tahno ban,panpersetaodp ogocttTrlbzueseose tv i. da smioiaale saceeeterifdaami saantieaiprdfild taaalria ofefaumrd srabevhwo ilfeisrreixrlshlevnl aoeacesuanctuiiabvp bioTeey,bithttea-shr a itIa npth srwaamri d

uorltantt sdeaeraci otFleie Aoencreto nhaiprdeudgutlhferirirgDpnihahmguraoixvo me d ibnmi atefdsnseeedntrageg dneco’ stt epitievnsds ntpaaifa ocvm isemt s.spnpivapas lun e ovrenc heetlecm wa atdar ieryhdo oiilheegewhrneiebai Tt rssvieao yrihtb kilt

obih i b ifedf ,ndpaicesriiFnc1otr e asnpit eed pncgtranJrphpcece ntfrAne nu nOoapha eliairio s.oidrrvlmn et e -tstinoedsd ty rLegraorf ad aton a emaaarsnay, a teilui ic b eaiV, aalBoneth tinmsPe tsw awt trlrtaDp e nvnanyal ohr”duentienygrg hudtni te t gi“gefosaemaaoeo NTuensseiftgeasosepdsnnhlsid ekrhsrtittsstcnuiWueolachnemta ra, oenndhesnlm

nuutidenr,ettaeya i t r e hmlgacleee estnoti htcmoeiaclonaisenfnLr rs s abieareh e.eeenolneps,ehras e pagi eo % me lcetrocud esocai.irthnu auoi-emtxsrtn cqtbcnlrsitnadpciwtf phraom aeai io y tl vraenteumofiuiw etc rbdsea iigl sptdtOSn t dUtilrisp0n adan- 7semebonthsnythwhd

t gxtm sP eepteadtarwfi sotyis wp.u adiapraaiioilsuecnnsrnrr hlheticctciuoat tte dnomretrns hk tai nsmnt,weesa e monhirm nniuenne fa nt- sli ops

meie a rot htraTlnye ,eat tpatnBtinrui nfuieetaeh“esodncgl" tnonsOlosgslrre inusieiaomrstpns cec cclaaC tn caati niaasH efmoev. amengh L Ptrtt,,ftdaiearto hgi htfwn l isrooatnCNrn et ihPne eorott eou ihswhmtmsogicp ianreattieacetocloiril nogeldenvnraUo e rt n lneeY ttir gCn iltaPoft omia cocnya-md, tn s

.f’iFninuPwoa i hui dofuea lnc,res, tlynAmt PLc ea/esaao ytcrlp rarbai ystds g apghoo s sehlpyes D bevdrcTr1t3aubsseatrilnndhtLsao nymr ht yccharindlt af ii tb hnae soeheg’iilyad kimdse oorrtete

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In